TAK-593(1005780-62-0)
- Name: TAK-593
- Synonyms:UNII-H3I42X8XX7;N-[5-({2-[(cyclopropylcarbonyl)amino]imidazo[1,2-b]pyridazin-6-yl}oxy)-2-methylphenyl]-1,3-dimethyl-1H-pyrazole-5-carboxamide;1H-Pyrazole-5-carboxamide,N-(5-((2-((cyclopropylcarbonyl)amino)imidazo(1,2-b)pyridazin-6-yl)oxy)-2-methylphenyl)-1,3-dimethyl;TAK 593;
- Molecular Formula:C23H23N7O3
- Molecular Weight:445.481
- CAS Registry Number:1005780-62-0
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1005780-62-0 TAK-593
Assay:99.99%HPLC Appearance:White crystalline powder Package:double PP bags with Al Storage:Inert atmosphere,Room Temperature Transportation:by air or by ocean shipping Application:Pharmaceutical Intermediates
Min. Order:0
Supplier:Shanghai Hope Chem Co., Ltd [
China (Mainland)] CAS No.1005780-62-0 TAK-593
Assay:>98% Appearance:white solid powder Package:inquiry Transportation:inquiry Application:TAK-593 is an oral formulation containing a small-molecule receptor tyrosine kinase inhibitor of both vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor recepto...
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 891495-88-8/SCH900776 raemic mixture
- 1228237-57-7/ARQ 736
- 1233948-35-0/ELR-510444
- 308145-19-9/2-Butene-1,4-diamine, N,N'-bis[3-(ethylamino)propyl]-, (2Z)-
- 875756-97-1/bisBenziMide H 33342 trihydrochloride
- 1269815-17-9/Piperidine-3-carboxylic acid [5-chloro-4-(5-fluoro-2-methoxy-phenyl)-pyridin-2-yl]-amide
- 1218779-75-9/N-[4-(1-Cyanocyclopentyl)phenyl]-2-[(4-pyridinylmethyl)amino]-3-pyridinecarboxamide methanesulfonate
- 445493-23-2/11107B
- 1177489-18-7/CASPASE-13 INHIBITOR I
- 1142214-62-7/AM-1638
- 4727-31-5/Kartogenin
- 195883-07-9/YM 273
- 865784-01-6/ON 013105
- 857070-65-6/1-((3-hydroxy-6-Methylpyridin-2-yl)Methyl)-2-((3-Morpholinopropyl)aMino)-1H-benzo[d]iMidazole-6-carbaldehyde
- 857067-38-0/2-((6-(hydroxyMethyl)-2-((3-Morpholinopropyl)aMino)-1H-benzo[d]iMidazol-1-yl)Methyl)-6-Methylpyridin-3-ol
- 245414-50-0/3-(((2R,3R)-4-((3S,4aS,8aS)-3-(tert-butylcarbaMoyl)octahydroisoquinolin-2(1H)-yl)-3-hydroxy-1-(phenylthio)butan-2-yl)carbaMoyl)-2-Methylphenyl acetate
- 857071-75-1/(E)-3-(4-Methyl-2-nitrophenyl)prop-2-en-1-ol
- 662151-10-2/ML-220
- 1354792-97-4/NI-07
- 1005780-62-0/TAK-593
- 926291-77-2/Benzeneethanol, β-aMino-3-chloro-, (βR)-
- 1286739-19-2/6-(2-Chloro-4-thiazol-5-yl-phenyl)-8-ethyl-2-[4-(4-Methyl-piperazin-1-yl)-phenylaMino]-8H-pyrido[2,3-d]pyriMidin-7-one
- 131918-62-2/19-nor-Doxercalciferol
- 1260907-17-2/GSK 525762A
- 333352-59-3/NBD-557
- 1096708-71-2/6-Amino-5-chloro-N-[(1R)-1-[5-[[[5-chloro-4-(trifluoromethyl)-2-pyridinyl]amino]carbonyl]-2-thiazolyl]ethyl]-4-pyrimidinecarboxamide
- 914462-92-3/Rolapitant hydrochloride
- 916151-99-0/LOR 253
- 929721-98-2/Impurity A of Maxacalcitol
- 1217835-38-5/(R)-(2,3-dimethyl-3-((trimethylsilyl)oxy)butyl)diphenylphosphine oxide